Literature DB >> 25245828

Capabilities, limitations, and misconceptions of using OCT to assess vulnerable plaques.

Mark E Brezinski1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25245828     DOI： 10.1038/nrcardio.2014.62-c1

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  6 in total

1.  Index matching to improve optical coherence tomography imaging through blood.

Authors:  M Brezinski; K Saunders; C Jesser; X Li; J Fujimoto
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

2.  Current capabilities and challenges for optical coherence tomography as a high-impact cardiovascular imaging modality.

Authors:  Mark E Brezinski
Journal:  Circulation       Date:  2011-06-28       Impact factor: 29.690

Review 3.  Clinical classification of plaque morphology in coronary disease.

Authors:  Fumiyuki Otsuka; Michael Joner; Francesco Prati; Renu Virmani; Jagat Narula
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 32.419

Review 4.  Applications of optical coherence tomography to cardiac and musculoskeletal diseases: bench to bedside?

Authors:  Mark E Brezinski
Journal:  J Biomed Opt       Date:  2007 Sep-Oct       Impact factor: 3.170

5.  Widespread coronary inflammation in unstable angina.

Authors:  Antonino Buffon; Luigi M Biasucci; Giovanna Liuzzo; Giuseppe D'Onofrio; Filippo Crea; Attilio Maseri
Journal:  N Engl J Med       Date:  2002-07-04       Impact factor: 91.245

6.  Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography.

Authors:  Guillermo J Tearney; Hiroshi Yabushita; Stuart L Houser; H Thomas Aretz; Ik-Kyung Jang; Kelly H Schlendorf; Christopher R Kauffman; Milen Shishkov; Elkan F Halpern; Brett E Bouma
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690
  6 in total
  1 in total

1.  Matching human pathology is essential for validating OCT imaging to detect high-risk plaques.

Authors:  Renu Virmani; Fumiyuki Otsuka; Francesco Prati; Jagat Narula; Michael Joner
Journal:  Nat Rev Cardiol       Date:  2014-09-23       Impact factor: 32.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.